Menu Search
Equities

Swedencare AB (publ)

  • Add to watchlist
  • Add to portfolio
  • Add an alert
7XY:FRA

Swedencare AB (publ)

Actions
  • Price (EUR)2.23
  • Today's Change0.025 / 1.14%
  • Shares traded44.00
  • 1 Year change-44.26%
  • Beta0.7963
Data delayed at least 15 minutes, as of Feb 06 2026 07:09 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Swedencare AB (publ) is a Sweden-based company which is mainly involved in the veterinary supplies industry. The company scope of activity includes manufacturing, developing and sale of products in the field of animal health care and preventive dental care products made of seaweed selected cold North Atlantic waters off the Scandinavian coastline. The Company operates as a provider of various products for animal health, distributed to veterinarians, pet stores as well as pharmacies. The Company's product portfolio includes ProDen product family, which consists of ProDen PlaqueOff Teeth and Gums, ProDen PlaqueOff Dental Bites, among others. The products are available at veterinary clinics, pet retailers, pharmacies, health stores and dentist practices.

  • Revenue in SEK (TTM)2.67bn
  • Net income in SEK63.00m
  • Incorporated1993
  • Employees609.00
  • Location
    Swedencare AB (publ)Per Albin Hanssons Vag 41MALMO 214 32SwedenSWE
  • Phone+46 4085933
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		SECARE:STO since
announced		Transaction
value
Summit Veterinary Pharmaceuticals LtdDeal completed24 Mar 202524 Mar 2025Deal completed-34.34%54.74m
Data delayed at least 15 minutes, as of Feb 06 2026 17:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.